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Synthesis of (Difluoromethyl)naphthalenes by Ring Construction 
Strategy: C–C Bond Formation on the Central Carbon of 1,1-
Difluoroallenes via Pd-Catalyzed Insertion 
Kohei Fuchibe, Shumpei Watanabe, Go Takao and Junji Ichikawa * 
The insertion of 1,1-difluoroallenes was carried out to form a C–C bond exclusively on their central carbon. o-
Bromophenyl-bearing 1,1-difluoroallenes underwent intramolecular insertion in the presence of a palladium catalyst. 
Regioselective C–C bond formation occurred to construct a six-membered carbocycle, leading to pharmaceutically and 
agrochemically promising difluoromethylated naphthalenes. 
Introduction 
The difluoromethyl (CHF2) group as a fluorinated functional 
group has attracted considerable attention. Its unique 
properties are attributed to the steric and electronic 
characteristics of fluorine.1 The CHF2 group is a bioisostere of a 
hydroxyl group and serves as a hydrogen donor for hydrogen 
bonding while simultaneously exhibiting hydrophobicity.2–4 On 
the basis of these facts, the number of difluoromethylated 
biologically active substances is definitely increasing. 
Among the difluoromethylated compounds, 
(difluoromethyl)arenes have been extensively investigated in 
terms of their synthesis, due to their abundance in bioactive 
compounds.5 Typical methods to synthesize 
(difluoromethyl)arenes include the (i) deoxyfluorination of 
aromatic aldehydes or their derivatives6 (ii) double C–H 
fluorination of methylarenes,7 and (iii) difluoromethylation of 
(pseudo)haloarenes8 or arylmetals9 by cross coupling 
reaction.10 However, all these methods require aromatic rings 
in the starting materials. From a synthetic point of view, a 
process for simultaneous formation of an aromatic nuclei and 
installation of a difluoromethyl group is desirable. 
In the past years, our group has developed metal-catalyzed 
or 
 -mediated reactions of 1,1-difluoroallenes,11 involving the C–C 
bond formation at the positions α and γ to the fluorine 
substituents, respectively (Scheme 1). (a) With respect to the 
regioselective C–C bond formation at the α position, 1,1-
difluoroallenes were treated with an indium(III) catalyst.12–14 
Metallated allylic CF2 cations, stabilized by the α-fluorine 
substituents,1 were generated and subsequently underwent 
domino  
 
Scheme 1  α-, γ-, and β-Selective C–C bond formations of 1,1-difluoroallenes 
by metal complexes (DDQ = 2,3-dichloro-5,6-dicyano-p-benzoquinone). 
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Scheme 2.  Preparation of 1,1-difluoroallenes. 
Friedel–Crafts-type cyclization/ring expansion, affording 
regioselectively monofluorinated PAHs (pinpoint-fluorinated 
PAHs), which are soluble p-type semiconducting materials.15 
Notably, the fluorination and construction of aromatic rings 
were simultaneously achieved during the synthesis of 
fluoroarenes. (b) The formation of a C–C bond at the γ position 
was achieved using a stoichiometric amount of 
organocopper(I) reagents.16 1,1-Difluoroallenes underwent 
regioselective insertion, forming a C–C bond at the position γ 
to the fluorine substituents to afford γ-branched 1,1-
difluoroalkenes.17 On the basis of the above-mentioned two 
reactions: (a) ring construction of arenes and (b) insertion with 
organometallics, the intramolecular insertion of 1,1-
difluoroallenes was envisioned to facilitate the synthesis of 
(difluoromethyl)arenes via ring construction,17 which permits 
the rare formation of C–C bonds at the position β to the 
fluorine substituents.18 
In this study, (difluoromethyl)naphthalenes were 
synthesized by the palladium(0)-catalyzed regioselective 
insertion of o-bromophenyl-bearing 1,1-difluoroallenes. 
Although the Pd-catalyzed intramolecular insertion of fluorine-
free allenes has been previously reported,19,20 the reactivities 
of 1,1-difluoroallenes are typically changed by the two 
fluorines, and their C–C bond formation via transition-metal-
catalyzed insertion has never been investigated. Thus, through 
the synthesis of (difluoromethyl)arenes, the unexplored 
insertion of difluoroallenes was achieved. 
Results and discussion 
For the difluorovinylidenation of carbonyl compounds, our 
protocol was adopted to prepare 1,1-difluoroallenes 1 (Scheme 
2).21 o-Bromophenyl-bearing aldehydes or ketones 2 were 
treated with 2,2-difluoro-1-iodovinyllithium, which was 
generated from commercially available 1,1,1-trifluoro-2-
iodoethane and LDA in a ratio of 1:2, followed by acetic 
anhydride, generating the corresponding iodoacetates. These 
acetates were subsequently treated with zinc metal, and 
IZnOAc was eliminated, affording the desired mono- or 
disubstituted 1,1-difluoroallenes 1. 
By using a model substrate 1a (R1–R3 = H), the catalyst 
system was investigated in the presence of ethanol20 (Table 1). 
Although palladium(II) acetate gave a complex mixture (entry 
1), Pd2(dba)3·CHCl3 afforded the desired 1-
(difluoromethyl)naphthalene 3a, albeit in 5% yield (entry 2). 
Triphenylphosphine-ligated 
Table 1. Effect of catalyst a 
 
Entry Pd complex, mol% Ligand (L), mol% Pd/L Ratio Cone Angle (θ) 3a (%) 
1 b Pd(OAc)2, 5 none – – CM 
2 Pd2(dba)3·CHCl3, 3 none – – 5 
3 c PdCl2(PPh3)2, 5 none – – 21 
4 Pd(PPh3)4, 5 none – – 32 
5 Pd2(dba)3·CHCl3, 3 PPh3, 6 1/1 145 23 
6 Pd2(dba)3·CHCl3, 3 Pp-Tol3, 6 1/1 145 d 23 
7 Pd2(dba)3·CHCl3, 3 P(C6H4p-OMe)3, 6 1/1 145 d 30 
8 Pd2(dba)3·CHCl3, 3 P(C6H4p-CF3)3, 6 1/1 149 25 
9 Pd2(dba)3·CHCl3, 3 PAr3, 6 1/1 175 38 
10 Pd2(dba)3·CHCl3, 3 Pm-Tol3, 6 1/1 184 42 
11 Pd2(dba)3·CHCl3, 3 Pm-Tol3, 12 1/2 184 24 
12 Pd2(dba)3·CHCl3, 3 Pm-Tol3, 24 1/4 184 25 
13 Pd2(dba)3·CHCl3, 3 Po-Tol3, 6 1/1 193 12 
14 Pd2(dba)3·CHCl3, 3 Cy-JohnPhos, 6 1/1 – 12 
15 Pd2(dba)3·CHCl3, 3 t-Bu-JohnPhos, 6 1/1 – 0 
16 Pd2(dba)3·CHCl3, 3 PCy3, 6 1/1 170 24 
17 Pd2(dba)3·CHCl3, 3 Pt-Bu3, 6 1/1 182 18 
18 Pd2(dba)3·CHCl3, 3 P(OEt)3, 6 1/1 109 14 
19 Pd2(dba)3·CHCl3, 3 P(OPh)3, 6 1/1 130 14 
a 19F NMR yield based on the internal standard PhCF3. b 7 h. c 80 °C, 15 h. d Value of PPh3. Ar = C6H33,5-Me2. Tol = tolyl.  
CM = complex mixture. 
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PdCl2(PPh3)2 and Pd(PPh3)4 afforded 3a in 21% and 32% yields 
(entries 3 and 4), respectively. Thus, ring construction via 
insertion proceeded as expected and the insertion exhibited 
similar regioselectivity reported in the corresponding fluorine-
free system, generating stable π-allylpalladium(II) 
intermediates (vide infra). 
Yields of 3a varied depending on the steric bulk of ligands L 
and the Pd/L ratio. By using triarylphosphines with 
Pd2(dba)3⋅CHCl3, yields of 3a exhibited a correlation with the 
Tolman cone angle θ (Pd/L = 1/1, entries 5–10, Table 1). Thus, 
Pm-Tol3 with a large θ (184°) afforded 3a in the highest yields 
(42%, entry 10), whereas extremely bulky ligands afforded 
poor results (entries 13–15). In addition, trialkylphosphines 
and phosphites afforded 3a in 14–24% yields (entries 16–19). 
Notably, the yields of 3a were also affected by the Pd/L ratio. 
The use of Pm-Tol3 with a Pd/L ratio of 1/1 afforded 3a in the 
highest yield (42%, entry 10), whereas higher ligand loadings 
(Pd/L = 1/2 and 1/4) led to lower yields of 3a (24% and 25% 
yields in entries 11 and 12), respectively. Relatedly, the use of 
bidentate ligands [3 mol% Pd2(dba)3·CHCl3, 6 mol% 
Ph2P(CH2)nPPh2 (n = 1–4) or 6 mol% dppf, Pd/P = 1/2] also 
afforded poor yields of 3a (9–16% yields, not shown).  
The concentration of 1a strongly affected the product yield 
(Table 2). Higher concentrations (0.5 and 0.1 mol/L, entries 1 
and 2) led to decreased yields of 3a to 4% and 19%, 
respectively, affording a complex reaction mixture. Reaction 
using higher concentrations presumably caused undesired 
intermolecular reactions. On the other hand, the reaction 
conducted using lower concentration (0.01 mol/L) led to the 
increased yield of 3a to 49% (entry 4), whereas highly diluted 
conditions (0.001 mol/L) afforded a lower yield (10%, entry 5). 
The survey of solvents revealed that DMF is the most suitable 
solvent for this insertion reaction (entries 6–9). Use of 50 equiv 
of ethanol led to generation of 3a in the highest 76% yield 
(entry 10). 
 
Table 2. Effect of substrate concentration and solvent a 
 
Entry Conditions 1a (mol/L) 3a (%) 1a (%) b 
1 DMF, 120 °C, 2 h 0.5 4 – 
2 DMF, 120 °C, 2 h 0.1 19 – 
3 c DMF, 120 °C, 2 h 0.04 42 – 
4 DMF, 120 °C, 2 h 0.01 49 – 
5 DMF, 120 °C, 2 h 0.001 10 – 
6 DMA, 110 °C, 2 h 0.04 12 – 
7 DMSO, 110 °C, 2 h 0.04 31 – 
8 1,4-Dioxane, 100 °C, 1 h 0.04 –  75 
9 Toluene, 110 °C, 2 h 0.04 – – 
10 d DMF, 120 °C, 2 h 0.01 76  – 
a 19F NMR yield based on the internal standard PhCF3. b Recovery. c Table 1, 
Entry 10. d EtOH 50 equiv. DMA = N,N-dimethylacetamide. 
 
 
Fig. 1  Synthesis of (difluoromethyl)naphthalenes [19F NMR yield based on 
the internal standard PhCF3 in parentheses; conditions: 1 (0.01 M), 3 mol% 
Pd2(dba)3·CHCl3, 6 mol% Pm-Tol3, EtOH 50 equiv, K2CO3 5.0 equiv, DMF, 
120 °C, 2 h]. 
(Difluoromethyl)naphthalenes were synthesized under the 
optimized conditions (Fig. 1). Electron-withdrawing and  
-donating groups on the tethered benzene ring did not affect 
the reaction. Thus, (difluoromethyl)naphthalenes 3a–f were 
isolated in 48–67% yields. In addition, disubstituted 
difluoroallenes participated in the reaction, affording 
naphthalene 3g in a decreased yield (52% by 19F NMR). 1,1-
Difluoroallenes bearing a methyl or phenyl group at the 
position δ to the fluorine substituents afforded corresponding 
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products 3h and 3i in 57% and 43% yields, respectively. This 
intramolecular insertion was applicable not only for six-
membered ring construction but also for five-membered ring 
construction. 1,1-Difluoroallene, having a CMe2 tether instead 
of an ethyelene tether afforded the corresponding 3j in 83% 
yield.22 
The plausible mechanism is described in Scheme 3. 
Bromoallenes 1 undergo oxidative addition to palladium(0), 
affording arylpalladium(II) bromides A. Intermediates A 
undergo regioselective insertion to generate more stable π-
allylpalladium(II) intermediates B, forming a C–C bond at the 
position β to the fluorine substituents.23 Taking the effects of 
the steric bulk of the ligand and the Pd/L ratio (1/1) into 
consideration (Table 1), it is supposed that the Pd(0)·L complex 
is the catalytically active species, and the steric bulk of the 
ligand can suppress the formation of Pd(0)·Ln complexes (n > 
1), which must be less reactive for the coordination and 
insertion of the difluoroallene moiety in A. β-Hydrogen 
elimination from σ-allylpalladium(II) intermediates C affords 
cyclic 1,1-difluoro-1,3-dienes 4, whose isomerization provides 
3. Shibasaki has reported that the use of pinacol as an additive 
for the Heck reaction of alkenyl triflates leads to the  
 
 
Scheme 3.  Proposed catalytic cycle. 
 
Scheme 4  The Tsuji–Trost reaction of difluorinated π-allylpalladium(II) 
intermediate (19F NMR yield based on the internal standard PhCF3 in 
parentheses). 
stabilization of a reactive Pd(0)·L2 complex.24,25 In the present 
system, ethanol might stabilize the reactive Pd(0)·L complex via 
coordination. 
This is the first example to generate terminally fluorinated 
π-allylpalladium(II) intermediates not through oxidative 
addition but insertion.26 The π-allylpalladium(II) intermediates 
thus-formed underwent Tsuji–Trost reaction at the position γ 
to the fluorine substituents (Scheme 4) and the corresponding 





In this study, the palladium-catalyzed C–C bond formation via 
intramolecular insertion of 1,1-difluoroallenes was 
accomplished for the first time. When o-bromophenyl-bearing 
1,1-difluoroallenes were treated with a Pd(0) complex, C–C 
bond formation at the position β to the fluorine substituents 
occurred, affording pharmaceutically and agrochemically 
promising (difluoromethyl)naphthalenes. Thus, the β-selective 
C–C bond formation reaction has newly joined the existing α- 
and γ-selective bond formation reactions of 1,1-difluroallenes. 
Experimental 
Preparation of 1,1-difluoroallenes 
1,1-Difluoroallenes 1a–j were prepared by our reported 
method.21 
5-(2-Bromo-4-chlorophenyl)-1,1-difluoropenta-1,2-diene (1b): 
1H NMR (500 MHz; CDCl3; SiMe4): δ 2.51–2.59 (m, 2H), 2.87 (dd, 
J =             22.6, 7.6 Hz, 1H), 2.89 (t, J = 7.7 Hz, 1H), 6.48 (tt, J = 
6.0 Hz, JHF = 2.5 Hz, 1H), 7.14 (d, J = 8.0 Hz, 1H), 7.23 (dd, J = 
8.0, 2.0 Hz, 1H), 7.56 (d, J = 2.0 Hz, 1H); 13C NMR (101 MHz; 
CDCl3; SiMe4): δ 31.9, 33.5, 120.6 (t, JCF = 5 Hz), 124.5, 127.7, 
131.0, 132.5, 132.8, 138.5, 152.9 (t, JCF = 260 Hz), 170.5 (t, JCF = 
36 Hz); 19F NMR (470 MHz; CDCl3; C6F6): δ 60.4 (br s); IR (neat): 
ν 2015, 1464, 1201, 818 cm–1; HRMS (EI): m/z calcd. for 
C11H8BrClF2 [M] +: 291.9466; Found: 291.9453. 
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5-[2-Bromo-4-(trifluoromethyl)phenyl]-1,1-difluoropenta-1,2-
diene (1c): 1H NMR (500 MHz; CDCl3; SiMe4): δ 2.55–2.63 (m, 2H), 
2.98 (t, J = 8.0 Hz, 2H), 6.49 (tt, J = 5.5 Hz, JHF = 2.5 Hz, 1H), 7.33 (d, J 
= 8.0 Hz, 1H), 7.51 (d, J = 8.0 Hz, 1H), 7.81 (s, 1H); 13C NMR (126 
MHz; CDCl3; SiMe4): δ 31.7, 34.1, 120.3 (t, JCF = 6 Hz), 123.2 (q, JCF = 
273 Hz), 124.4 (q, JCF = 4 Hz), 124.5, 130.0 (q, JCF = 6 Hz), 130.5 (q, JCF 
= 33 Hz), 130.6, 144.1, 153.0 (t, JCF = 262 Hz), 170.9 (t, JCF = 36 Hz); 
19F NMR (470 MHz, CDCl3; C6F6): δ 60.6 (br s, 2F), 99.1 (s, 3F); IR 
(neat): ν 2941, 2011, 1462, 1321, 1122, 1171, 1078, 829 cm–1; 
HRMS (EI): m/z calcd. for C12H8BrF5 [M]+: 325.9730; Found: 
325.9731. 
5-(2-Bromo-5-methoxylphenyl)-1,1-difluoropenta-1,2-diene (1d): 
1H NMR (400 MHz; CDCl3; SiMe4): δ 2.55 (m, 2H), 2.86 (t, J = 7.8 Hz, 
2H), 3.76 (s, 3H), 6.48 (tt, J = 6.0 Hz, JHF = 2.4 Hz, 1H), 6.64 (dd, J = 
8.8, 3.0 Hz, 1H), 6.75 (d, J = 3.0 Hz, 1H), 7.40 (d, J = 8.8 Hz, 1H); 13C 
NMR (101 MHz; CDCl3; SiMe4): δ 32.0, 34.3, 55.3, 113.6, 114.7, 
116.1, 121.0 (t, JCF = 5 Hz), 133.4, 140.8, 152.8 (t, JCF = 260 Hz), 
159.0, 170.2 (t, JCF = 36 Hz); 19F NMR (376 MHz, CDCl3; C6F6): δ 60.3–
60.4 (m); IR (neat): ν 2937, 2837, 2011, 1460, 1240, 1190, 1055, 802 
cm–1; HRMS (EI): m/z calcd. for C12H11BrF2O [M]+: 287.9961; Found: 
287.9949. 
5-(2-Bromo-5-fluoro-4-methylphenyl)-1,1-difluoropenta-1,2-diene 
(1e): 1H NMR (400 MHz; CDCl3; SiMe4): δ 2.22 (s, 3H), 2.50–2.59 (m, 
2H), 2.86 (t, J = 7.8 Hz, 2H), 6.47 (tt, J = 6.0 Hz, JHF = 2.6 Hz, 1H), 6.87 
(d, JHF = 10.0 Hz, 1H), 7.35 (d, J = 6.8 Hz, 1H); 13C NMR (101 MHz; 
CDCl3; SiMe4): δ 13.9 (d, JCF = 3 Hz), 31.9, 33.8, 116.7 (d, JCF = 24 Hz), 
117.8 (d, JCF = 3 Hz), 120.7 (t, JCF = 5 Hz), 125.0 (d, JCF = 18 Hz), 135.1 
(d, JCF = 6 Hz), 139.0 (d, JCF = 7 Hz), 152.9 (t, JCF = 260 Hz), 160.4 (d, 
JCF = 244 Hz), 170.5 (t, JCF = 36 Hz); 19F NMR (376 MHz, CDCl3; C6F6): 
δ 42.5 (ddq, JHF = 10, 7, 1 Hz, 1F), 60.4 (td, JFH = 6, 3 Hz, 2F); IR 
(neat): ν 2931, 2866, 2011, 1485, 1460, 1192, 1134, 881 cm–1; 
HRMS (EI): m/z calcd. for C12H10BrF3 [M]+: 289.9918; Found: 
289.9922. 
5-(2-Bromo-4,6-dimethylphenyl)-1,1-difluoropenta-1,2-diene (1f): 
1H NMR (400 MHz; CDCl3; SiMe4): δ 2.25 (s, 3H), 2.31 (s, 3H), 2.37–
2.49 (m, 2H), 2.92 (t, J = 8.0 Hz, 2H), 6.48–6.55 (m, 1H), 6.91 (s, 1H), 
7.23 (s, 1H); 13C NMR (101 MHz; CDCl3; SiMe4): δ 20.4, 20.5, 30.7, 
31.1, 121.4 (t, JCF = 5 Hz), 125.1, 130.5, 131.2, 135.2, 137.5, 137.7, 
152.8 (t, JCF = 259 Hz), 169.9 (t, JCF = 36 Hz); 19F NMR (376 MHz, 
CDCl3; C6F6): δ 60.2–60.3 (m); IR (neat): ν 2951, 2920, 2009, 1460, 
1190, 955, 850 cm–1; HRMS (EI): m/z calcd. for C13H13BrF2 [M]+: 
286.0169; Found: 286.0181. 
5-(2-Bromophenyl)-3-methyl-1,1-difluoropenta-1,2-diene (1g): 1H 
NMR (500 MHz; CDCl3; SiMe4): δ 1.98 (t, JHF = 5.0 Hz, 3H), 2.48 (tt, J 
= 8.0 Hz, JHF = 5.5 Hz, 2H), 2.89 (t, J = 8.0 Hz, 2H), 7.07 (ddd, J = 7.8, 
7.0, 2.1 Hz, 1H), 7.18–7.25 (m, 2H), 7.53 (dd, J = 7.0, 1.2 Hz, 1H); 13C 
NMR (126 MHz; CDCl3; SiMe4): δ 22.9, 33.9, 37.0, 124.3, 127.5, 
127.9, 130.3, 132.0 (t, JCF = 6 Hz), 132.9, 140.3, 150.4 (t, JCF = 260 
Hz), 163.2 (t, JCF = 35 Hz); 19F NMR (470 MHz, CDCl3; C6F6): δ 61.6 (tq, 
JFH = 5.5, 5.0 Hz); IR (neat): ν 2993, 2922, 2004, 1479, 1176, 1159, 
748 cm–1; HRMS (EI): m/z calcd. for C12H11BrF2 [M]+: 272.0012; 
Found: 272.0005. 
5-(2-Bromophenyl)-4-methyl-1,1-difluoropenta-1,2-diene (1h): 1H 
NMR (400 MHz; CDCl3; SiMe4): δ 1.06–1.14 (m, 3H), 2.65–2.88 (m, 
2H), 2.88–3.00 (m, 1H), 6.45 (ddd, J = 7.6, 5.2, 2.4 Hz, 1H), 7.02–7.13 
(m, 1H), 7.13–7.20 (m, 1H), 7.20–7.32 (m, 1H), 7.54 (dd, J = 8.4, 3.6 
Hz, 1H); 13C NMR (101 MHz; CDCl3; SiMe4): δ 18.5, 36.7, 42.0, 124.7, 
126.5 (dd, JCF = 5, 5 Hz), 127.3, 128.1, 131.4, 133.0, 138.9, 153.4 (dd, 
JCF = 259, 259 Hz), 168.9 (dd, JCF = 36, 36 Hz); 19F NMR (376 MHz, 
CDCl3; C6F6): δ 60.1 (dm, J = 121 Hz, 1F), 60.5 (dm, J = 121 Hz, 1F); IR 
(neat): ν 2968, 2931, 2009, 1446, 1238, 1194, 746 cm–1; HRMS (EI): 
m/z calcd. for C12H11BrF2 [M]+: 272.0012; Found: 272.0005. 
5-(2-Bromophenyl)-4-phenyl-1,1-difluoropenta-1,2-diene (1i): 1H 
NMR (500 MHz; CDCl3; SiMe4): δ 3.03 (dd, J = 14.0, 7.5 Hz, 1H), 3.32 
(dd, J = 14.0, 7.5 Hz, 1H), 3.91–3.99 (m, 1H) 6.62 (ddd, J = 6.5 Hz, JHF 
= 2.5, 2.5 Hz, 1H), 6.86 (d, J = 7.5 Hz, 1H), 7.03 (dd, J = 7.5, 7.5 Hz, 
1H), 7.08 (dd, J = 7.5, 7.5 Hz, 1H), 7.14 (d, J = 8.0 Hz, 2H), 7.23 (dd, J 
= 7.5, 7.5 Hz, 1H), 7.29 (dd, J = 7.5, 7.5 Hz, 2H), 7.52 (d, J = 7.5 Hz, 
1H); 13C NMR (126 MHz; CDCl3; SiMe4): δ 41.7, 48.0, 123.9 (dd, JCF = 
6, 6 Hz), 124.6, 127.1, 127.2, 128.0, 128.1, 128.6, 131.6, 132.8, 
138.3, 140.6, 153.4 (dd, JCF = 263, 263 Hz), 170.4 (dd, JCF = 37, 37 
Hz); 19F NMR (470 MHz, CDCl3; C6F6): δ 60.7 (ddd, J = 119 Hz, JFH = 4, 
3 Hz, 1F), 61.5 (ddd, J = 119 Hz, JFH = 5, 3 Hz, 1F); IR (neat): ν 3030, 
2925, 2009, 1450, 1194, 744, 698 cm–1; HRMS (EI): m/z calcd. for 
C17H13BrF2 [M]+: 334.0169; Found: 334.0173. 
4-(2-Bromophenyl)-4-methyl-1,1-difluoropenta-1,2-diene (1j): 1H 
NMR (500 MHz; CDCl3; SiMe4): δ 1.62 (s, 6H), 6.75 (t, JHF = 2.4 Hz, 
1H) 7.11 (ddd, J = 7.6, 7.6, 1.6 Hz, 1H), 7.30 (ddd, J = 7.6, 7.6, 1.6 Hz, 
1H), 7.43 (dd, J = 7.6, 1.6 Hz, 1H), 7.61 (dd, J = 7.6, 1.6 Hz, 1H); 13C 
NMR (101 MHz; CDCl3; SiMe4): δ 28.1, 43.8, 123.2, 127.4, 128.0, 
128.5, 130.7 (t, JCF = 6 Hz), 135.5, 144.5, 153.2 (t, JCF = 260 Hz), 
167.6 (t, JFC = 36 Hz); 19F NMR (470 MHz, CDCl3; C6F6): δ 60.9 (d, JFH = 
2 Hz); IR (neat): ν 2974, 2009, 1435, 1192, 752 cm–1; HRMS (EI): m/z 
calcd. for C12H11BrF2 [M]+: 272.0012; Found: 272.0018. 
Synthesis of (difluoromethyl)naphthalenes and 
(difluoromethyl)indenes 
Synthesis of 3a is described as a typical procedure. The mixture 
of Pd2(dba)3·CHCl3 (4.0 mg, 3.9 mol%), Pm-Tol3 (2.4 mg, 7.8 
mol%), K2CO3 (89.9 mg, 0.650 mmol), ethanol (0.380 ml, 6.50 
mmol) in DMF (10 mL) was stirred for 15 min at room 
temperature under argon. A solution of 1a (33.6 mg, 0.130 
mmol) in DMF (3 mL) was added to the mixture, and then 
heated to 120 °C. After stirring for 2 h at the same 
temperature, the mixture was cooled to room temperature, 
and then PhCF3 (16.2 mg, 0.111 mmol) was added as an 
internal standard. (Difluoromethyl)naphthalene 3a was 
obtained in 76% yield that determined by 19F NMR. The 
reaction was quenched with aq. NaOH (2 mol/L, 15 mL), and 
the organic products were extracted with Et2O. The combined 
organic layers were washed with water, brine and dried over 
anhydrous Na2SO4. After removal of the solvent under reduced 
pressure, the residue was purified by column chromatography 
(pentane). 1-(Difluoromethyl)naphthalene 3a was obtained as 
a colorless liquid (14.0 mg, 60%). The spectral data of 3a met 
complete agreement with those in literature.8b 
7-Chloro-1-(difluoromethyl)naphthalene (3b): 1H NMR (500 MHz; 
CDCl3; SiMe4): δ 7.06 (t, JHF = 55.0 Hz, 1H), 7.47–7.53 (m, 2H), 7.70 
(dd, J = 7.1, 1.0 Hz, 1H), 7.85 (d, J = 8.8 Hz, 1H), 7.94 (d, J = 8.3 Hz, 
1H), 8.16 (s, 1H); 13C NMR (126 MHz; CDCl3; SiMe4): δ 115.2 (t, JCF = 
239 Hz), 122,88, 122.90, 124.9, 125.9 (t, JCF = 9 Hz), 127.4, 128.9 (t, 
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JCF = 21 Hz), 130.2, 131.3, 132.0, 133.3; 19F NMR (470 MHz, CDCl3; 
C6F6): δ 51.0 (d, JFH = 55 Hz); IR (neat): ν 3059, 2974, 1583, 1502, 
1176, 1113, 1092, 1020, 829, 750 cm–1; HRMS (EI): m/z calcd. for 
C11H7ClF2 [M]+: 212.0204; Found: 212.0199. 
1-Difluoromethyl-7-(trifluoromethyl)naphthalene (3c): 1H NMR 
(500 MHz; CDCl3; SiMe4): δ 7.13 (t, JHF = 54.8 Hz, 1H), 7.64 (dd, J = 
7.7 Hz, 1H), 7.74 (dd, J = 8.7, 1.4 Hz, 1H), 7.78 (d, J = 7.0 Hz, 1H), 
8.03 (d, J = 8.7 Hz, 2H) 8.49 (s, 1H); 13C NMR (126 MHz; CDCl3; 
SiMe4): δ 115.1 (t, JCF = 240 Hz), 121.6 (q, JCF = 5 Hz), 122.2 (q, JCF = 3 
Hz), 124.1 (q, JCF = 273 Hz), 126.2 (t, JCF = 9 Hz), 126.9, 128.7, 129.1 
(q, JCF = 32 Hz), 129.8, 130.7 (t, JCF = 21 Hz), 131.4, 135.0; 19F NMR 
(470 MHz, CDCl3; C6F6): δ 51.4 (d, JFH = 55 Hz, 2F), 99.3 (s, 3F); IR 
(neat): ν 1315, 1165, 1122, 1076, 1028, 839 cm–1; HRMS (EI): m/z 
calcd. for C12H7F5 [M]+: 246.0468; Found: 246.0477. 
1-Difluoromethyl-6-methoxynaphthalene (3d): 1H NMR (400 MHz; 
CDCl3; SiMe4): δ 3.91 (s, 3H), 7.05 (t, JHF = 55.2 Hz, 1H), 7.18 (d, J = 
2.6 Hz, 1H), 7.24 (dd, J = 9.2, 2.6 Hz, 1H), 7.43 (dd, J = 7.6, 7.6 Hz, 
1H), 7.51 (d, J = 7.6 Hz, 1H), 7.83 (d, J = 7.6 Hz, 1H), 8.07 (d, J = 9.2 
Hz, 1H); 13C NMR (101 MHz; CDCl3; SiMe4): δ 55.3, 106.7, 115.6 (t, JCF 
= 237 Hz), 119.8, 122.6 (t, JCF = 9 Hz), 125.0, 125.15, 125.23, 129.6 
(t, JCF = 21 Hz), 130.3, 135.3, 157.8; 19F NMR (376 MHz, CDCl3; C6F6): 
δ 51.5 (d, JFH = 55 Hz); IR (neat): ν 2960, 2933, 1630, 1518, 1261, 
1105, 1022 cm–1; HRMS (EI): m/z calcd. for C12H10F2O [M]+: 
208.0700; Found: 208.0697. 
1-Difluoromethyl-6-fluoro-7-methylnaphthalene (3e): 1H NMR (500 
MHz; CDCl3; SiMe4): δ 2.48 (s, 3H), 7.05 (t, JHF = 55.1 Hz, 1H), 7.44 (t, 
J = 7.5 Hz, 1H), 7.46 (d, J = 9.0, 1H), 7.59 (d, J = 7.5 Hz, 1H), 7.84 (d, J 
= 9.0 Hz, 1H), 7.98 (d, J = 7.5 Hz, 1H); 13C NMR (126 MHz; CDCl3; 
SiMe4): δ 15.6 (d, JCF = 4 Hz), 111.4 (d, JCF = 22 Hz), 115.6 (t, JCF = 239 
Hz), 124.2 (td, JCF = 9, 2 Hz), 124.8, 126.0 (d, JCF = 6 Hz), 127.4 (d, JCF 
= 21 Hz), 128.0 (d, JCF = 10 Hz), 129.1 (t, JCF = 21 Hz), 130.5 (d, JCF = 5 
Hz), 133.7 (d, JCF = 10 Hz), 160.2 (d, JCF = 249 Hz); 19F NMR (470 MHz, 
CDCl3; C6F6): δ 44.1 (dd, J = 9, 9 Hz, 1F), 51.5 (d, JFH = 55 Hz, 2F); IR 
(neat): ν 2966, 1514, 1250, 1095, 1026, 870 cm–1; HRMS (EI): m/z 
calcd. for C12H9F3 [M]+: 210.0656; Found: 210.0663. 
1-Difluoromethyl-5,7-dimethylnaphthalene (3f): 1H NMR (400 
MHz; CDCl3; SiMe4): δ 2.51 (s, 3H), 2.68 (s, 3H), 7.13 (t, JHF = 55.2 Hz, 
1H), 7.24 (s, 1H), 7.46 (dd, J = 7.8, 7.8 Hz, 1H), 7.67 (d, J = 7.8 Hz, 
1H), 7.77 (s, 1H), 8.08 (d, J = 7.8 Hz, 1H); 13C NMR (101 MHz; CDCl3; 
SiMe4): δ 19.7, 22.1, 115.4 (t, JCF = 237 Hz), 120.6, 123.6, 124.4 (t, JCF 
= 9 Hz), 127.3, 129.2 (t, JCF = 21 Hz), 129.5, 130.3, 131.2, 134.8, 
136.7; 19F NMR (376 MHz, CDCl3; C6F6): δ 50.7 (d, JFH = 55 Hz); IR 
(neat): ν 2974, 1383, 1134, 1016, 810, 758, 748 cm–1; HRMS (EI): 
m/z calcd. for C13H12F2 [M]+: 206.0907; Found: 206.0912. 
1-Difluoromethyl-2-methylnaphthalene (3g): 1H NMR (500 MHz; 
CDCl3; SiMe4): δ 2.64 (t, J = 1.9 Hz, 3H), 7.29 (d, J = 8.5 Hz, 1H), 7.37 
(t, JHF = 54.0 Hz, 1H), 7.47 (dd, J = 7.2 Hz, 1H), 7.55 (ddd, J = 8.4, 7.2, 
1.4 Hz, 1H), 7.83 (d, J = 8.4 Hz, 2H), 8.34 (d, J = 8.5 Hz, 1H); 13C NMR 
(126 MHz; CDCl3; SiMe4): δ 19.5, 114.7 (t, JCF = 236 Hz), 124.3 (t, JCF 
= 3 Hz), 125.5, 126.2, 127.0, 128.5, 129.0, 130.4, 131.2, 132.7, 135.4 
(t, JCF = 7 Hz); 19F NMR (470 MHz, CDCl3; C6F6): δ 52.6 (d, J = 54 Hz); 
IR (neat): ν  2927, 1818, 1512, 1186, 1099, 1036, 1011, 814, 742 
cm–1; HRMS (EI): m/z calcd. for C12H10F2 [M]+: 192.0751; Found: 
192.0730. 
1-Difluoromethyl-3-methylnaphthalene (3h): 1H NMR (500 MHz; 
CDCl3; SiMe4): δ 2.53 (s, 3H), 7.10 (t, JHF = 55.3 Hz, 1H), 7.50–7.55 
(m, 3H), 7.72 (s, 1H), 7.80–7.84 (m, 1H), 8.08–8.13 (m, 1H); 13C NMR 
(126 MHz; CDCl3; SiMe4): δ 21.5, 115.4 (t, JCF = 239 Hz), 123.3, 126.2, 
126.4, 127.0 (t, JCF = 9 Hz), 127.9, 128.1 (t, JCF = 13 Hz), 129.3 (t, JCF = 
21 Hz), 130.3, 134.1, 134.4; 19F NMR (470 MHz, CDCl3; C6F6): δ 50.8 
(d, JFH = 55 Hz); IR (neat): ν: 2966, 1514, 1346, 1111, 1018, 877, 748 
cm–1; HRMS (EI): m/z calcd. for C12H10F2 [M]+: 192.0751; Found: 
192.0758.   
1-Difluoromethyl-3-phenylnaphthalene (3i): 1H NMR (500 MHz; 
CDCl3; SiMe4): δ 2.51 (s, 3H), 2.68 (s, 3H), 7.13 (t, JHF = 55.2 Hz, 1H), 
7.24 (s, 1H), 7.46 (dd, J = 7.8, 7.8 Hz, 1H), 7.67 (d, J = 7.8 Hz, 1H), 
7.77 (s, 1H), 8.08 (d, J = 7.8 Hz, 1H); 13C NMR (126 MHz; CDCl3; 
SiMe4): δ 115.4 (t, JCF = 239 Hz), 123.4, 124.6 (t, JCF = 9 Hz), 126.8, 
127.2, 127.3, 127.8, 128.8, 129.0, 129.1, 130.1 (t, JCF = 21 Hz), 134.2, 
137.6, 140.1; 19F NMR (470 MHz, CDCl3; C6F6): δ 50.7 (d, JFH = 55 Hz); 
IR (neat): ν 3060, 2924, 1603, 1346, 1246, 1113, 1022, 889 cm–1; 
HRMS (EI): m/z calcd. for C17H12F2 [M]+: 254.0907; Found: 254.0919.  
3-Difluoromethyl-1,1-dimethylindene (3j): 1H NMR (500 MHz; 
CDCl3; SiMe4): δ 1.35 (s, 6H), 6.60 (t, JHF = 3.0 Hz, 1H), 6.62 (t, JHF = 
55.3 Hz, 1H), 7.21–7.30 (m, 2H), 7.32–7.37 (m, 1H), 7.43–7.48 (m, 
1H); 13C NMR (126 MHz; CDCl3; SiMe4): δ 24.0, 49.0, 112.8 (t, JCF = 
234 Hz), 120.9, 121.5, 126.2, 126.7, 134.5 (t, JCF = 23 Hz), 137.8, 
147.1 (t, JCF = 9 Hz), 153.5; 19F NMR (470 MHz, CDCl3; C6F6): δ 47.2 
(dd, JFH = 55, 3 Hz); IR (neat): ν 2962, 2925, 2856, 1469, 1375, 1022, 
818, 771 cm–1; HRMS (EI): m/z calcd. for C12H12F2 [M]+: 194.0907; 
Found: 194.0905. 
1-Difluoromethylidene-2-di(ethoxycarbonyl)methyl-1,2,3,4-
tetrahydronaphthalene (5): 1H NMR (500 MHz; CDCl3; SiMe4): δ 
1.22 (t, J = 7.1 Hz, 3H), 1.25 (t, J = 7.1 Hz, 3H), 1.97–2.09 (m, 2H), 
2.81 (ddd, J = 17.7, 5.9, 3.8 Hz, 1H), 2.88 (ddd, J = 17.7, 10.7, 6.9 Hz, 
1H), 3.43 (d, J = 11.1 Hz, 1H), 3.61–3.67 (m, 1H), 4.13 (dq, J = 10.9, 
7.1 Hz, 1H), 4.17 (dq, J = 10.9, 7.1 Hz, 1H), 4.20 (q, J = 7.1 Hz, 2H), 
7.11–7.15 (m, 1H), 7.18 (dd, J = 3.5, 3.5 Hz, 1H), 7.19 (dd, J = 3.5, 3.5 
Hz, 1H), 7.43 (ddd, J = 5.7, 3.5, 3.5 Hz, 1H); 13C NMR (126 MHz; 
CDCl3; SiMe4): δ 13.9, 14.0, 25.1, 25.3, 32.7, 52.9, 61.4, 61.5, 90.0 
(dd, JCF = 22, 11 Hz), 126.3, 127.2, 127.4 (dd, JCF = 4, 4 Hz), 128.0, 
128.1, 129.0, 135.49, 135.53, 152.9 (dd, JCF = 293, 286 Hz); 19F NMR 
(470 MHz, CDCl3; C6F6): δ 73.5 (d, J = 36 Hz, 1F), 76.8 (d, J = 36 Hz, 
1F); IR (neat): ν 2981, 2937, 1755, 1728, 1240, 1032, 766 cm–1; 
HRMS (EI): m/z calcd. for C18H20F2O4 [M]+: 338.1330; Found: 
338.1325. 
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